UK statutory group audit of a pharmaceutical company listed on German exchange
UK statutory group audit of a pharmaceutical company listed on German exchange
UK Plc listed on German exchange; pharmaceutical holding company with international drug development and commercialisation focused on oncology treatments.
Audit scope and key challenges
Investment valuation and impairment testing
Group consolidation across multiple jurisdictions
Business combination and fair value accounting
Complex equity funding transactions
Foreign currency translation
Going concern assessment and liquidity analysis
Our approach
Impairment testing on subsidiary investments
Component auditor coordination
Business combination
Funding arrangements and cash flow forecast evaluation